Detail akcie Brooks Aut online

Business Summary: Azenta, Inc. is a provider of life sciences solutions worldwide. The Company provides a full suite of cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions globally. The Company's segments include Sample Management Solutions and Multiomics. Its Sample Management Solutions segment offers end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The Company's Multiomics segment includes its genomic services business, which advances research and development activities by providing gene sequencing, synthesis, editing and related services. The Company's brands include GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.
Financial Summary: BRIEF: For the fiscal year ended 30 September 2025, Azenta Inc revenues increased 4% to $593.8M. Net income before extraordinary items totaled $24.5M vs. loss of $24.4M. Revenues reflect Multiomics segment increase of 6% to $269.2M, Sample management solutions segment increase of 2% to $324.6M, Rest of Europe segment increase of 13% to $107.4M, United Kingdom segment increase of 30% to $35.4M, Asia/Pacific segment increase of 9% to $23.3M.